Chris M. Bunce
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
The challenge of defining and understanding monoclonal gammopathy of undetermined significance.
Journal: British journal of haematology
Published: November 07, 2025
SIGNIFIED: whole-body MRI screening in Li-Fraumeni syndrome in the UK.
Journal: ESMO open
Published: September 26, 2025
Recognising disease progression in MGUS and smouldering myeloma: Biomarkers, symptom monitoring and imaging.
Journal: British journal of haematology
Published: August 08, 2025
Li Fraumeni syndrome in the UK: clinical characteristics and outcomes of TP53 carriers.
Journal: ESMO open
Published: March 23, 2025
Whole genome sequencing-powered ctDNA sequencing for breast cancer detection.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 15, 2024
Association of post-operative ctDNA detection with outcomes of patients with early breast cancers.
Journal: ESMO open
Published: January 17, 2024
Does the pursuit of scientific excellence serve or hamper translational medical research: an historical perspective from hematological malignancies.
Journal: Blood cancer journal
Published: July 14, 2022
Visual outcome following posterior capsule rupture during manual small incision cataract surgery.
Journal: Nigerian journal of clinical practice
Published: June 14, 2021
Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing.
Journal: British journal of cancer
Published: June 07, 2021
Trends in diabetic retinopathy screening attendance and associations with vision impairment attributable to diabetes in a large nationwide cohort.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: July 02, 2020
Dissecting racial disparities in multiple myeloma-clues from differential immunoglobulin levels.
Journal: Blood cancer journal
Published: March 10, 2020
Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers.
Journal: Contemporary clinical trials communications
Published: January 16, 2019
Last Updated: 09/26/2026